{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["399(10323)"],"submitter":["Attard G"],"funding":["Swiss Group for Clinical Cancer Research","Janssen LP","Cancer Research UK","Medical Research Council","National Institute for Health Research (NIHR)","Astellas Pharma Inc"],"journal":["Lancet (London, England)"],"pagination":["447-460"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8811484"],"repository":["biostudies-literature"],"pubmed_title":["Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol."],"pmcid":["PMC8811484"],"funding_grant_id":["3804","12518","28284","NF-SI-0611-10106","19727","NF-SI-0617-10099","MC_UU_12023/25","MC_UU_00004/01","22744"],"pubmed_authors":["John H","Brawley C","Tanguay J","Sheehan D","Smith-Howell M","Syndikus I","Fackrell D","Berthold D","Narahari K","Vilarino-Varela M","Robson P","Parmar MKB","Douglas F","Bloomfield D","Kagzi M","Ahmed I","Taylor H","Hughes R","Sabharwal A","Pereira Mestre R","Thalmann G","Masters B","Sreenivasan T","Mason MD","Conroy R","Bahl A","Attard G","Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators","Borner M","James ND","Chan A","Paisey S","Shaffer R","Wylie J","Ibrahim A","Strebel R","Cook A","Hoskin P","Brock S","Durr D","Dealey R","Hofmann U","Sundar S","Pedley I","Nikapota A","Porfiri E","Thomas C","Sydes MR","Lee L","Parikh O","Jones E","Cross W","Pugh C","Falconer A","Melcher L","Dearnaley DP","Perna C","Sayers I","Birtle A","Tipples K","Gillessen S","Glen H","Carser J","Khan MM","Sivoglo V","Tran A","Rudman S","Mullessey V","Crabb S","Matheson D","Azzabi A","Gray E","Afshar M","Hingorani M","McPhail N","Logue J","Parker CC","Brown LC","Woodward C","Gilson C","Gibbs S","Srihari N","Sidek N","Beyer J","Jones RJ","Sangar V","Mullassery V","Hamid A","Shaheen A","Porter T","Simms M","Brulinski P","Protheroe A","Gupta N","Roggero E","Lydon A","Alzoueb M","Amos CL","Phan MD","Gilbert D","Buckner M","Rentsch C","Engeler D","Hyde K","Clarke NW","McGovern U","Graham J","Vengalil S","Rush H","Bhalla N","Russell JM","Bowen J","Hilman S","Vivekanandan S","Khan Y","de Bono JS","Chowdhury S","Beresford M","Das P","Alameddine M","Brierly R","Wagstaff J","Rogers P","Zarkar A","Boussios S","Murphy L","Leaning D","Capaldi L","Popescu R","Millman R","Walker G","Grant W","Peedell C","O'Sullivan JM","McLaren D","Gale J","Atako N","Langley RE","Worlding J","Whelan P","Joseph J","Pezaro C","Robinson A","Mazhar D","Khoo V","Needleman S","Ford D","Khan O","Keng-Koh P","Malik Z","Kumar A","Brown S","Muthukumar D","Manetta C","Tarver K"],"additional_accession":[]},"is_claimable":false,"name":"Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan","modification":"2026-05-31T05:01:23.361Z","creation":"2025-02-19T01:53:37.691Z"},"accession":"S-EPMC8811484","cross_references":{"pubmed":["34953525"],"doi":["10.1016/S0140-6736(21)02437-5"]}}